XSHE
300405
Market cap249mUSD
Oct 09, Last price
5.83CNY
1D
-0.85%
1Q
14.09%
Jan 2017
-52.18%
IPO
-14.93%
Name
Liaoning Kelong Fine Chemical Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Liaoning Kelong Fine Chemical,Inc. manufactures and sells building materials additives, chemical products, and surfactants worldwide. It polycarboxylic acid water reducing agent polyether monomer, polycarboxylic acid water reducing agent, polycarboxylic acid water reducing agent powder, ethylene glycol phenyl ether series products, hydroxy acrylate, ethylene carbonate, ultraviolet light, graphene zinc powder coating, and surfactant. The company was founded in 2002 and is based in Liaoyang, China.
Key people
Yan Jiang
Chairman of the Board, General Manager · since 2009
Ning Wang
Chief Financial Officer · since 2024
Hongyu He
Deputy General Manager, Secretary of the Board · since 2023
Quankai Zhou
Deputy General Manager, Director · since 2009
Yong Jiang
Director, Chief Sales Officer · since 2020
Yunjun Pu
Director · since 2009
Licui Qin
Director · since 2025
Lei Zhang
Director · since 2021
Yiyun Gao
Independent Director · since 2022
Qiaoming Hou
Independent Director · since 2021
Dongxue Liu
Independent Director · since 2021
Headquarters & legal address
辽宁省辽阳市宏伟区万和七路36号
辽阳市, LN 110000
CN
辽阳市, LN 110000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||